New BBI Solutions Novarum Feature to Support Covid-19 Certificates
BBI Solutions' patented Novarum technology transforms a smartphone into a covid-19 diagnostics test reader.
BBI Solutions' patented Novarum technology transforms a smartphone into a covid-19 diagnostics test reader.
Fluxergy has obtained CE marking for its one-hour COVID-19 RT-PCR test, for use by healthcare professionals as an IVD for the detection of SARS-CoV-2.
Early detection, monitoring, and noninvasive diagnostic testing are essential to controlling this epidemic.
Guardant Health is joining forces with leading patient advocacy groups to expand the Clear Your View initiative to raise awareness of the important role complete biomarker testing plays in guiding initial treatment decisions for newly diagnosed advanced colorectal cancer patients.
This new B. burgdorferi IgG/IgM VlsE-OspC EIA test, when used in conjunction with the other FDA cleared GSD Lyme EIA tests, can be used in the CDC recommended modified two-tiered testing (MTTT) algorithm.
Offering insurance coverage of non-invasive prenatal testing to all pregnant women increases utlilization at a cost of less than 3 cents per member per month.
Automation using Nova View and the Nova Lite DAPI dsDNA Crithidia luciliae Kit can significantly improve laboratory turnaround time and reduce technician hands-on time.
Doctors may soon be able to more accurately diagnose concussions by measuring the microRNA in a person's saliva, according to a new study.
Unlike plasma or serum-based assays, PreADx takes an intracellular approach and measures the clearance of beta-amyloid peptides by analyzing a patient’s monocytes.
EKF Diagnostics' Stat-Site WB measures whole blood β-ketone and glucose levels in seconds.
A perspective article published in CJASN examines how the use of race in calculating kidney function, as well as other aspects of health, can cause harm to patients.
The breath biomarker panel is intended to support research to distinguish between chronic inflammatory airway diseases including asthma, COPD, and IPF.
The UT Dallas researchers' sensor is a portable device that monitors a panel of five immune biomarkers using only a single drop of blood plasma, making a sepsis diagnosis available within minutes.